Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,152 | -18,547 | -10,093 | -21,911 | -10,615 |
| Depreciation Amortization | 2,372 | 1,567 | 774 | 1,290 | 638 |
| Accounts payable and accrued liabilities | -703 | -955 | -980 | 878 | 824 |
| Other Working Capital | -1,036 | -1,491 | -2,015 | 438 | 42 |
| Other Operating Activity | 4,411 | 3,914 | 3,190 | 2,816 | -167 |
| Operating Cash Flow | $-21,108 | $-15,512 | $-9,124 | $-16,489 | $-9,278 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -433 | -198 | -94 | -420 | -359 |
| Net Acquisitions | N/A | N/A | N/A | 428 | 126 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -511 | -511 |
| Other Investing Activity | 0 | 0 | 0 | -511 | -511 |
| Investing Cash Flow | $-433 | $-198 | $-94 | $-503 | $-744 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 7,500 | 7,500 | 7,500 | 6,850 | 5,000 |
| Common Stock Issued | 26,643 | 26,698 | N/A | 37,718 | 6,361 |
| Other Financing Activity | 0 | 0 | 0 | -1,000 | 0 |
| Financing Cash Flow | $34,143 | $34,198 | $7,500 | $43,568 | $11,361 |
| Beginning Cash Position | 31,667 | 31,667 | 31,667 | 5,091 | 5,091 |
| End Cash Position | 44,269 | 50,155 | 29,949 | 31,667 | 6,430 |
| Net Cash Flow | $12,602 | $18,488 | $-1,718 | $26,576 | $1,339 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,108 | -15,512 | -9,124 | -16,489 | -9,278 |
| Capital Expenditure | -433 | -198 | -94 | -420 | -359 |
| Free Cash Flow | -21,541 | -15,710 | -9,218 | -16,909 | -9,637 |